Anne Wojcicki

Anne Wojcicki is co-founder and serves as CEO and board member of 23andMe. She is also president and chair of the Anne Wojcicki Foundation. Before founding the firm in 2006, she spent 10 years investing in health care, mostly in biotechnology companies. She is also a general partner at Covalence Life Sciences Partners. Before joining Covalence, she was a senior research analyst at Amerindo Investment Advisors. Prior to that, Ms. Wojcicki worked at Andor Capital Management as a health care analyst, Ardsley Partners as a health care analyst and Investor AB as a senior health care analyst. Ms. Wojcicki also worked at the National Institutes of Health as a research fellow in oncology and hematology. She also worked at the Weizmann Institute as a Biochemistry Fellow and at Yale University as a Research Fellow in the Department of Biochemistry. Ms. Wojcicki received her bachelor’s degree in biology from Yale University in 1996.

About Anne Wojcicki

Prominent biotechnologist Anne Wojcicki co-founded 23andMe in 2006, sparking a move toward consumer-driven genetic testing. Her organization provides consumers with usable health data by providing insights into personal health, ancestry, and genetic predispositions. It is based in South San Francisco, California. Under her direction, 23andMe went public in 2021 via a SPAC, demonstrating her aptitude at negotiating tricky financial situations and popularizing genomic technology.

Education

In 1996, Anne Wojcicki completed her biology coursework and earned a B.S. from Yale University. Participating in varsity ice hockey and competitive ice skating during her academic career demonstrated her commitment and self-control. Wojcicki’s solid background in science and team sports equipped him to take on the challenges of spearheading a trailblazing business in the quickly changing biotech sector.

Family

Prior to her current union, Google co-founder Sergey Brin and Anne Wojcicki were married and had two children together. Her sister Susan Wojcicki was the CEO of YouTube, while her other sister Janet Wojcicki works as an epidemiologist at UCSF. She comes from an impressive family. Her career has been greatly impacted by her dynamic familial background, which has instilled a strong entrepreneurial spirit and a passion to science and technology.

Interesting Facts

Anne Wojcicki completed many personal projects and achieved a great deal during her career. Outside of her managerial position, she has actively participated in community development through her real estate holding company in Los Altos, California, and the Brin Wojcicki Foundation. Her leadership in the field of healthcare innovation was further cemented when GSK invested a substantial sum of money in 23andMe’s medication development. Furthermore, her significant contributions to genetic research and public health were recognized in 2008 when Time magazine named her company’s retail saliva genetic test Invention of the Year.